How the African Medicines Agency can reduce regulatory fragmentation, strengthen pharmaceutical manufacturing and accelerate access to quality-assured medical products across Africa.
Audio By Vocalize
African Medicines Agency.[Courtesy]
Last week, during a discussion with African vaccine manufacturers, one manufacturer asked me a deceptively simple question:
Can the African Medicines Agency help make it easier for a manufacturer to reach multiple African markets without navigating a completely separate process in every country?
It is a question I have encountered throughout my career as a regulator, and one that goes to the heart of why the African Medicines Agency matters.
Africa cannot build a sustainable pharmaceutical manufacturing industry while retaining permanently fragmented pathways to its…
Africa’s biotechnology and biosafety information which had been scattered across multiple agency websites, making it difficult…
South Africa’s pharmaceutical manufacturing ambitions will depend on resolving fundamental challenges around affordability,…
African countries to receive support as part of efforts to allow in-country producers to play a larger role in making medicines…
South Africa’s pharmaceutical manufacturing industry has secured a commitment from senior government officials to jointly review…
Manufacturers say pricing pressures and supply disruptions threaten domestic production
